Nath, C. E., Trotman, J., Tiley, C., Presgrave, P., Joshua, D., Kerridge, I., . . . Shaw, P. J. (2016). High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation. Br J Clin Pharmacol.
Chicago-tyylinen lähdeviittausNath, Christa E., et al. "High Melphalan Exposure Is Associated With Improved Overall Survival in Myeloma Patients Receiving High Dose Melphalan and Autologous Transplantation." Br J Clin Pharmacol 2016.
MLA-viiteNath, Christa E., et al. "High Melphalan Exposure Is Associated With Improved Overall Survival in Myeloma Patients Receiving High Dose Melphalan and Autologous Transplantation." Br J Clin Pharmacol 2016.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.